• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测亲水性药物在单层脂质体中的包封。

Predicting hydrophilic drug encapsulation inside unilamellar liposomes.

机构信息

Department of Pharmaceutical Sciences, University of Connecticut, 69 N Eagleville Rd U3092, Storrs, CT 06269, United States.

出版信息

Int J Pharm. 2012 Feb 28;423(2):410-8. doi: 10.1016/j.ijpharm.2011.12.019. Epub 2011 Dec 21.

DOI:10.1016/j.ijpharm.2011.12.019
PMID:22207162
Abstract

A mathematical model has been developed to predict the encapsulation efficiency of hydrophilic drugs in unilamellar liposomes, and will be useful in formulation development to rapidly achieve optimized formulations. This model can also be used to compare drug encapsulation efficiencies of liposomes prepared via different methods, and will assist in the development of suitable process analytical technologies to achieve real-time monitoring and control of drug encapsulation during liposome manufacturing for hydrophilic molecules. Liposome particle size as well as size distribution, lipid concentration, lipid molecular surface area, and bilayer thickness were used in constructing the model. Most notably, a Log-Normal probability function was utilized to account for sample particle size distribution. This is important to avoid significant estimation error. The model-generated predictions were validated using experimental results as well as literature data, and excellent correlations were obtained in both cases. A Langmuir balance study provided insight regarding the effect of media on the liposome drug encapsulation process. The results revealed an inverse correlation between media ionic strength and lipid average molecular area, which helps to explain the phenomenon of inverse correlation between media ionic strength and drug encapsulation efficiency. Finally, a web application has been written to facilitate use of the model allowing calculations to be easily performed. This model will be useful in formulation development to rapidly achieve optimized formulation.

摘要

已经开发出一种数学模型来预测亲水性药物在单层脂质体中的包封效率,这将有助于制剂开发,从而快速实现优化的配方。该模型还可用于比较通过不同方法制备的脂质体的药物包封效率,并有助于开发合适的过程分析技术,以实现对亲水分子脂质体制造过程中药物包封的实时监测和控制。该模型使用了脂质体粒径以及粒径分布、脂质浓度、脂质分子表面积和双层厚度来构建。值得注意的是,利用对数正态概率函数来解释样品粒径分布。这一点很重要,可以避免估计误差过大。使用实验结果和文献数据对模型生成的预测进行了验证,两种情况下都得到了很好的相关性。Langmuir 平衡研究提供了关于介质对脂质体药物包封过程影响的见解。结果表明,介质离子强度与脂质平均分子面积之间呈反比关系,这有助于解释介质离子强度与药物包封效率之间的反比关系现象。最后,编写了一个网络应用程序来方便使用该模型,从而可以轻松地进行计算。该模型将有助于制剂开发,从而快速实现优化的配方。

相似文献

1
Predicting hydrophilic drug encapsulation inside unilamellar liposomes.预测亲水性药物在单层脂质体中的包封。
Int J Pharm. 2012 Feb 28;423(2):410-8. doi: 10.1016/j.ijpharm.2011.12.019. Epub 2011 Dec 21.
2
A quality by design (QbD) case study on liposomes containing hydrophilic API: II. Screening of critical variables, and establishment of design space at laboratory scale.载亲水 API 的脂质体的质量源于设计(QbD)案例研究:II. 关键变量的筛选和实验室规模的设计空间的建立。
Int J Pharm. 2012 Feb 28;423(2):543-53. doi: 10.1016/j.ijpharm.2011.11.036. Epub 2011 Dec 1.
3
Peritoneal retention of liposomes: Effects of lipid composition, PEG coating and liposome charge.脂质体在腹膜中的保留:脂质组成、PEG 涂层和脂质体荷电性的影响。
J Control Release. 2010 Dec 1;148(2):177-86. doi: 10.1016/j.jconrel.2010.08.026. Epub 2010 Aug 26.
4
A quality by design (QbD) case study on liposomes containing hydrophilic API: I. Formulation, processing design and risk assessment.载亲水 API 的脂质体的质量源于设计(QbD)案例研究:I. 配方、工艺设计与风险评估。
Int J Pharm. 2011 Oct 31;419(1-2):52-9. doi: 10.1016/j.ijpharm.2011.07.012. Epub 2011 Jul 19.
5
A two-stage reverse dialysis in vitro dissolution testing method for passive targeted liposomes.被动靶向脂质体的两阶段反向透析体外溶出试验方法。
Int J Pharm. 2012 Apr 15;426(1-2):211-218. doi: 10.1016/j.ijpharm.2012.01.030. Epub 2012 Jan 23.
6
Lyophilization of cholesterol-free PEGylated liposomes and its impact on drug loading by passive equilibration.无胆固醇的聚乙二醇化脂质体的冷冻干燥及其对通过被动平衡药物装载的影响。
Int J Pharm. 2012 Jul 1;430(1-2):167-75. doi: 10.1016/j.ijpharm.2012.04.036. Epub 2012 Apr 16.
7
The effect of different lipid components on the in vitro stability and release kinetics of liposome formulations.不同脂质成分对脂质体制剂体外稳定性和释放动力学的影响。
Drug Deliv. 2004 Jan-Feb;11(1):33-9. doi: 10.1080/10717540490265243.
8
Influence of cholesterol on liposome stability and on in vitro drug release.胆固醇对脂质体稳定性及体外药物释放的影响。
Drug Deliv Transl Res. 2015 Jun;5(3):231-42. doi: 10.1007/s13346-015-0220-8.
9
Gemcitabine and tamoxifen-loaded liposomes as multidrug carriers for the treatment of breast cancer diseases.载有吉西他滨和他莫昔芬的脂质体作为治疗乳腺癌疾病的多药载体。
Int J Pharm. 2012 Jan 17;422(1-2):229-37. doi: 10.1016/j.ijpharm.2011.10.056. Epub 2011 Nov 9.
10
Copper ion-mediated liposomal encapsulation of mitoxantrone: the role of anions in drug loading, retention and release.铜离子介导的米托蒽醌脂质体包封:阴离子在药物负载、保留和释放中的作用。
Eur J Pharm Sci. 2008 Aug 7;34(4-5):333-44. doi: 10.1016/j.ejps.2008.05.006. Epub 2008 Jun 3.

引用本文的文献

1
Development and Evaluation of Trans-Resveratrol-Loaded Transfersomes: Role of Cholesterol in Formulation Design for Dermal Delivery.载有反式白藜芦醇的传递体的开发与评价:胆固醇在皮肤给药制剂设计中的作用。
Nanotechnol Sci Appl. 2025 Jul 31;18:359-375. doi: 10.2147/NSA.S529010. eCollection 2025.
2
Co-Encapsulation of Multiple Antineoplastic Agents in Liposomes by Exploring Microfluidics.通过微流控技术实现多种抗肿瘤药物在脂质体中的共包封
Int J Mol Sci. 2025 Apr 17;26(8):3820. doi: 10.3390/ijms26083820.
3
Potential of the Nano-Encapsulation of Antioxidant Molecules in Wound Healing Applications: An Innovative Strategy to Enhance the Bio-Profile.
抗氧化分子纳米封装在伤口愈合应用中的潜力:一种增强生物特性的创新策略。
Molecules. 2025 Jan 31;30(3):641. doi: 10.3390/molecules30030641.
4
Advancements in Liposomal Nanomedicines: Innovative Formulations, Therapeutic Applications, and Future Directions in Precision Medicine.脂质体纳米药物的进展:创新制剂、治疗应用及精准医学的未来方向
Int J Nanomedicine. 2025 Jan 31;20:1213-1262. doi: 10.2147/IJN.S488961. eCollection 2025.
5
Advancing liposome technology for innovative strategies against malaria.推进脂质体技术以制定对抗疟疾的创新策略。
Saudi Pharm J. 2024 Jun;32(6):102085. doi: 10.1016/j.jsps.2024.102085. Epub 2024 Apr 24.
6
Immunogenicity of Recombinant Lipid-Based Nanoparticle Vaccines: Danger Signal vs. Helping Hand.基于脂质的重组纳米颗粒疫苗的免疫原性:危险信号与助力之手
Pharmaceutics. 2023 Dec 23;16(1):24. doi: 10.3390/pharmaceutics16010024.
7
Overcoming Skin Barrier with Transfersomes: Opportunities, Challenges, and Applications.利用传递体克服皮肤屏障:机遇、挑战与应用
Curr Drug Deliv. 2025;22(2):160-180. doi: 10.2174/0115672018272012231213100535.
8
Liposomal Encapsulation of Citicoline for Ocular Drug Delivery.用于眼部给药的胞磷胆碱脂质体包封
Int J Mol Sci. 2023 Nov 28;24(23):16864. doi: 10.3390/ijms242316864.
9
Lipid polymer hybrid nanoparticles: a custom-tailored next-generation approach for cancer therapeutics.脂质聚合物杂化纳米粒:一种为癌症治疗定制的新一代方法。
Mol Cancer. 2023 Oct 3;22(1):160. doi: 10.1186/s12943-023-01849-0.
10
Evaluation of a static mixer as a new microfluidic method for liposome formulation.评估静态混合器作为脂质体制备的一种新型微流控方法。
Front Bioeng Biotechnol. 2023 Aug 22;11:1229829. doi: 10.3389/fbioe.2023.1229829. eCollection 2023.